EMR: Emerson Electric Co Financial Statements
Balance sheet, income statement, and cash flow statements for Emerson Electric Co (EMR).
$62.64B Market Cap.
EMR Market Cap. (MRY)
EMR Shares Outstanding (MRY)
EMR Assets (MRY)
Total Assets
$44.25B
Total Liabilities
$16.74B
Total Investments
$0
EMR Income (MRY)
Revenue
$17.49B
Net Income
$1.97B
Operating Expense
$6.58B
EMR Cash Flow (MRY)
CF Operations
$3.33B
CF Investing
-$5.36B
CF Financing
-$2.46B
EMR Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $44,246,000,000 (3.51%) | $42,746,000,000 (19.83%) | $35,672,000,000 (44.33%) | $24,715,000,000 (8.01%) |
Assets Current | $10,192,000,000 (-26.25%) | $13,819,000,000 (62.46%) | $8,506,000,000 (0.88%) | $8,432,000,000 (-4.25%) |
Assets Non-Current | $34,054,000,000 (17.72%) | $28,927,000,000 (6.48%) | $27,166,000,000 (66.84%) | $16,283,000,000 (15.68%) |
Goodwill & Intangible Assets | $28,503,000,000 (37.41%) | $20,743,000,000 (1.10%) | $20,518,000,000 (93.57%) | $10,600,000,000 (15.19%) |
Shareholders Equity | $21,636,000,000 (4.58%) | $20,689,000,000 (99.62%) | $10,364,000,000 (4.87%) | $9,883,000,000 (17.58%) |
Property Plant & Equipment Net | $2,807,000,000 (18.79%) | $2,363,000,000 (5.54%) | $2,239,000,000 (-40.10%) | $3,738,000,000 (1.36%) |
Cash & Equivalents | $3,588,000,000 (-55.43%) | $8,051,000,000 (346.29%) | $1,804,000,000 (-23.36%) | $2,354,000,000 (-28.99%) |
Accumulated Other Comprehensive Income | -$868,000,000 (30.73%) | -$1,253,000,000 (15.62%) | -$1,485,000,000 (-70.30%) | -$872,000,000 (44.71%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $3,255,000,000 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $3,255,000,000 (0%) | $0 (0%) | $0 (0%) |
Inventory | $2,180,000,000 (8.67%) | $2,006,000,000 (15.15%) | $1,742,000,000 (-15.02%) | $2,050,000,000 (6.33%) |
Trade & Non-Trade Receivables | $2,927,000,000 (16.24%) | $2,518,000,000 (11.37%) | $2,261,000,000 (-23.90%) | $2,971,000,000 (6.03%) |
Trade & Non-Trade Payables | $1,335,000,000 (4.71%) | $1,275,000,000 (-0.08%) | $1,276,000,000 (-39.47%) | $2,108,000,000 (22.92%) |
Accumulated Retained Earnings (Deficit) | $40,830,000,000 (1.90%) | $40,070,000,000 (42.84%) | $28,053,000,000 (7.70%) | $26,047,000,000 (4.38%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $7,687,000,000 (-5.76%) | $8,157,000,000 (-21.37%) | $10,374,000,000 (55.65%) | $6,665,000,000 (-10.97%) |
Debt Current | $532,000,000 (-2.74%) | $547,000,000 (-74.14%) | $2,115,000,000 (142.55%) | $872,000,000 (-24.83%) |
Debt Non-Current | $7,155,000,000 (-5.98%) | $7,610,000,000 (-7.86%) | $8,259,000,000 (42.57%) | $5,793,000,000 (-8.43%) |
Total Liabilities | $16,737,000,000 (3.65%) | $16,148,000,000 (-16.57%) | $19,356,000,000 (30.85%) | $14,792,000,000 (2.47%) |
Liabilities Current | $5,742,000,000 (14.11%) | $5,032,000,000 (-35.30%) | $7,777,000,000 (24.51%) | $6,246,000,000 (7.97%) |
Liabilities Non-Current | $10,995,000,000 (-1.09%) | $11,116,000,000 (-4.00%) | $11,579,000,000 (35.49%) | $8,546,000,000 (-1.20%) |
EMR Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $17,492,000,000 (15.34%) | $15,165,000,000 (9.86%) | $13,804,000,000 (6.74%) | $12,932,000,000 (-22.96%) |
Cost of Revenue | $8,607,000,000 (11.23%) | $7,738,000,000 (3.20%) | $7,498,000,000 (4.11%) | $7,202,000,000 (-26.33%) |
Selling General & Administrative Expense | $5,142,000,000 (22.84%) | $4,186,000,000 (15.83%) | $3,614,000,000 (3.43%) | $3,494,000,000 (-12.34%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $6,576,000,000 (40.15%) | $4,692,000,000 (13.53%) | $4,133,000,000 (8.39%) | $3,813,000,000 (-15.60%) |
Interest Expense | $175,000,000 (414.71%) | $34,000,000 (-82.47%) | $194,000,000 (25.16%) | $155,000,000 (-0.64%) |
Income Tax Expense | $415,000,000 (-35.36%) | $642,000,000 (16.94%) | $549,000,000 (58.67%) | $346,000,000 (0.29%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $1,955,000,000 (-85.19%) | $13,200,000,000 (308.67%) | $3,230,000,000 (38.81%) | $2,327,000,000 (16.93%) |
Net Income to Non-Controlling Interests | -$13,000,000 (31.58%) | -$19,000,000 (-1800.00%) | -$1,000,000 (-104.17%) | $24,000,000 (-4.00%) |
Net Income | $1,968,000,000 (-85.11%) | $13,219,000,000 (309.13%) | $3,231,000,000 (40.30%) | $2,303,000,000 (17.20%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $1,968,000,000 (-85.11%) | $13,219,000,000 (309.13%) | $3,231,000,000 (40.30%) | $2,303,000,000 (17.20%) |
Weighted Average Shares | $571,300,000 (-0.51%) | $574,200,000 (-3.15%) | $592,900,000 (-0.87%) | $598,100,000 (-0.80%) |
Weighted Average Shares Diluted | $574,000,000 (-0.57%) | $577,300,000 (-3.19%) | $596,300,000 (-0.91%) | $601,800,000 (-0.79%) |
Earning Before Interest & Taxes (EBIT) | $2,558,000,000 (-81.59%) | $13,895,000,000 (249.65%) | $3,974,000,000 (41.73%) | $2,804,000,000 (13.71%) |
Gross Profit | $8,885,000,000 (19.63%) | $7,427,000,000 (17.78%) | $6,306,000,000 (10.05%) | $5,730,000,000 (-18.25%) |
Operating Income | $2,309,000,000 (-15.58%) | $2,735,000,000 (25.86%) | $2,173,000,000 (13.35%) | $1,917,000,000 (-23.04%) |
EMR Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$5,360,000,000 (-143.17%) | $12,415,000,000 (332.75%) | -$5,334,000,000 (-151.60%) | -$2,120,000,000 (-186.49%) |
Net Cash Flow from Financing | -$2,455,000,000 (64.02%) | -$6,823,000,000 (-433.15%) | $2,048,000,000 (184.56%) | -$2,422,000,000 (-375.83%) |
Net Cash Flow from Operations | $3,332,000,000 (423.08%) | $637,000,000 (-78.20%) | $2,922,000,000 (-18.27%) | $3,575,000,000 (15.96%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$4,463,000,000 (-171.44%) | $6,247,000,000 (1235.82%) | -$550,000,000 (42.77%) | -$961,000,000 (-152.77%) |
Net Cash Flow - Business Acquisitions and Disposals | -$4,827,000,000 (-140.22%) | $12,001,000,000 (345.07%) | -$4,897,000,000 (-189.59%) | -$1,691,000,000 (-1242.06%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $918,000,000 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$419,000,000 (-15.43%) | -$363,000,000 (-21.40%) | -$299,000,000 (25.99%) | -$404,000,000 (24.91%) |
Issuance (Repayment) of Debt Securities | -$567,000,000 (82.51%) | -$3,242,000,000 (-187.84%) | $3,691,000,000 (554.56%) | -$812,000,000 (-149.51%) |
Issuance (Purchase) of Equity Shares | -$435,000,000 (78.25%) | -$2,000,000,000 (-300.00%) | -$500,000,000 (0.00%) | -$500,000,000 (46.92%) |
Payment of Dividends & Other Cash Distributions | -$1,201,000,000 (-0.25%) | -$1,198,000,000 (2.04%) | -$1,223,000,000 (-1.07%) | -$1,210,000,000 (-0.08%) |
Effect of Exchange Rate Changes on Cash | $20,000,000 (11.11%) | $18,000,000 (109.68%) | -$186,000,000 (-3200.00%) | $6,000,000 (146.15%) |
Share Based Compensation | $260,000,000 (4.00%) | $250,000,000 (100.00%) | $125,000,000 (-36.55%) | $197,000,000 (79.09%) |
Depreciation Amortization & Accretion | $1,689,000,000 (60.70%) | $1,051,000,000 (24.82%) | $842,000,000 (10.50%) | $762,000,000 (-10.77%) |
EMR Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 50.80% (3.67%) | 49.00% (7.22%) | 45.70% (3.16%) | 44.30% (5.98%) |
Profit Margin | 11.30% (-87.04%) | 87.20% (272.65%) | 23.40% (31.46%) | 17.80% (52.14%) |
EBITDA Margin | 24.30% (-75.35%) | 98.60% (182.52%) | 34.90% (26.45%) | 27.60% (39.39%) |
Return on Average Equity (ROAE) | 9.40% (-88.76%) | 83.60% (168.81%) | 31.10% (25.40%) | 24.80% (1.64%) |
Return on Average Assets (ROAA) | 4.30% (-87.05%) | 33.20% (232.00%) | 10.00% (5.26%) | 9.50% (5.56%) |
Return on Sales (ROS) | 14.60% (-84.06%) | 91.60% (218.06%) | 28.80% (32.72%) | 21.70% (47.62%) |
Return on Invested Capital (ROIC) | 15.10% (-82.56%) | 86.60% (236.96%) | 25.70% (7.53%) | 23.90% (4.82%) |
Dividend Yield | 1.90% (-13.64%) | 2.20% (-21.43%) | 2.80% (33.33%) | 2.10% (-32.26%) |
Price to Earnings Ratio (P/E) | 31.79 (657.18%) | 4.2 (-68.80%) | 13.46 (-44.99%) | 24.47 (21.65%) |
Price to Sales Ratio (P/S) | 3.57 (-2.30%) | 3.66 (16.25%) | 3.15 (-27.82%) | 4.36 (85.01%) |
Price to Book Ratio (P/B) | 2.9 (8.51%) | 2.67 (-36.13%) | 4.18 (-26.69%) | 5.7 (22.22%) |
Debt to Equity Ratio (D/E) | 0.77 (-0.90%) | 0.78 (-58.19%) | 1.87 (24.78%) | 1.5 (-12.81%) |
Earnings Per Share (EPS) | 3.44 (-85.04%) | 23 (322.79%) | 5.44 (41.30%) | 3.85 (18.10%) |
Sales Per Share (SPS) | 30.62 (15.93%) | 26.41 (13.44%) | 23.28 (7.68%) | 21.62 (-22.33%) |
Free Cash Flow Per Share (FCFPS) | 5.1 (968.97%) | 0.48 (-89.22%) | 4.42 (-16.56%) | 5.3 (25.61%) |
Book Value Per Share (BVPS) | 37.87 (5.11%) | 36.03 (106.13%) | 17.48 (5.79%) | 16.52 (18.53%) |
Tangible Assets Book Value Per Share (TABVPS) | 27.56 (-28.09%) | 38.32 (49.92%) | 25.56 (8.30%) | 23.6 (4.01%) |
Enterprise Value Over EBIT (EV/EBIT) | 28 (600.00%) | 4 (-69.23%) | 13 (-40.91%) | 22 (22.22%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 16.59 (363.04%) | 3.58 (-67.05%) | 10.87 (-36.20%) | 17.04 (28.69%) |
Asset Turnover | 0.38 (0.52%) | 0.38 (-10.77%) | 0.43 (-20.19%) | 0.54 (-30.34%) |
Current Ratio | 1.77 (-35.36%) | 2.75 (151.01%) | 1.09 (-18.96%) | 1.35 (-11.30%) |
Dividends | $2.1 (0.96%) | $2.08 (0.97%) | $2.06 (1.98%) | $2.02 (1.00%) |
Free Cash Flow (FCF) | $2,913,000,000 (963.14%) | $274,000,000 (-89.55%) | $2,623,000,000 (-17.28%) | $3,171,000,000 (24.60%) |
Enterprise Value (EV) | $70,440,199,000 (31.56%) | $53,541,755,000 (2.26%) | $52,359,986,000 (-13.83%) | $60,765,760,000 (38.23%) |
Earnings Before Tax (EBT) | $2,383,000,000 (-82.81%) | $13,861,000,000 (266.69%) | $3,780,000,000 (42.70%) | $2,649,000,000 (14.68%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $4,247,000,000 (-71.58%) | $14,946,000,000 (210.34%) | $4,816,000,000 (35.05%) | $3,566,000,000 (7.41%) |
Invested Capital | $14,100,000,000 (-17.43%) | $17,077,000,000 (7.09%) | $15,947,000,000 (30.93%) | $12,180,000,000 (0.94%) |
Working Capital | $4,450,000,000 (-49.36%) | $8,787,000,000 (1105.35%) | $729,000,000 (-66.65%) | $2,186,000,000 (-27.64%) |
Tangible Asset Value | $15,743,000,000 (-28.45%) | $22,003,000,000 (45.20%) | $15,154,000,000 (7.36%) | $14,115,000,000 (3.18%) |
Market Capitalization | $62,636,199,000 (13.49%) | $55,189,755,000 (27.47%) | $43,294,986,000 (-23.12%) | $56,312,760,000 (43.71%) |
Average Equity | $21,002,250,000 (32.84%) | $15,810,000,000 (52.37%) | $10,375,750,000 (11.57%) | $9,299,750,000 (15.62%) |
Average Assets | $45,696,000,000 (14.74%) | $39,826,750,000 (23.33%) | $32,292,500,000 (33.61%) | $24,169,250,000 (10.58%) |
Invested Capital Average | $16,974,750,000 (5.74%) | $16,053,250,000 (3.79%) | $15,467,500,000 (31.85%) | $11,731,000,000 (8.30%) |
Shares | 572,700,000 (0.21%) | 571,500,000 (-3.35%) | 591,300,000 (-1.09%) | 597,800,000 (0.03%) |
